Treatments Explored for Moderate-to-Severe Alopecia Areata
Improvement in lesional scalp transcriptome toward nonlesional profile seen at week 24 for both ritlecitinib, brepocitinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.